727
Views
21
CrossRef citations to date
0
Altmetric
Case Reports

Optic neuropathy after COVID-19 vaccination: a report of two cases

ORCID Icon, , , , ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 901-907 | Received 13 Jun 2021, Accepted 29 Nov 2021, Published online: 14 Dec 2021

References

  • Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. N Engl J Med. 2020;383(25):2451–2460.
  • Zhou S, Jones-Lopez EC, Soneji DJ, et al. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19. J Neuroophthalmol. 2020;40(3):398–402.
  • Bhagali R, Prabhudesai NP, Prabhudesai MN. Post COVID-19 opportunistic candida retinitis: a case report. Indian J Ophthalmol. 2021;69(4):987–989.
  • Bapaye MM, Nair AG, Bapaye CM, et al. Simultaneous bilateral Central retinal artery occlusion following COVID-19 infection. Ocul Immunol Inflamm. 2021;29(4):671–674.
  • Yahalomi T, Pikkel J, Arnon R, et al. Central retinal vein occlusion in a young healthy COVID-19 patient: a case report. Am J Ophthalmol Case Rep. 2020;20:100992.
  • Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020;95(5):221–223.
  • Gutierrez-Ortiz C, Mendez-Guerrero A, Rodrigo-Rey S, et al. Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601–e605.
  • Polack FP, Thomas SJ, Kitchin N, C4591001 Clinical Trial Group, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
  • Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111.
  • Cines DB, Bussel JB. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med. 2021;384(23):2254–2256.
  • See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. Jama. 2021;325(24):2448.
  • Schoenmaker L, Witzigmann D, Kulkarni JA, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 2021;601:120586.
  • Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13(3):215–224.
  • Kawasaki A, Purvin VA, Tang R. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol. 1998;18(1):56–59.
  • Manasseh G, Donovan D, Shao EH, et al. Bilateral sequential non-arteritic anterior ischaemic optic neuropathy following repeat influenza vaccination. Case Rep Ophthalmol. 2014;5(2):267–269.
  • Phylactou M, Li JO, Larkin DFP. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol. 2021;105(7):893–896.
  • Cheng JY, Margo CE. Ocular adverse events following vaccination overview and update. Surv Ophthalmol. 2021. DOI:10.1016/j.survophthal.2021.04.001
  • Pulendran B, Arunachalam PS, O’Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021;20(6):454–475.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.